Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe. With Biofarm joining the Group, Polpharma is expanding the scale of its operations, reinforcing its presence in key regional markets, and creating new opportunities to improve patients’ access to trusted medicines across the region and beyond.

Biofarm’s acquisition reflects the Group’s ambition to grow internationally while staying true to its core priorities: responsibility towards patients and contributing to the modern and sustainable development of healthcare systems.

The integration of the Romanian company increases Polpharma’s scale, strengthens its presence in key Central and Eastern European markets, and enables better use of manufacturing, operational, and commercial capabilities developed across the region.